ELOXX PHARMACEUTICALS INC (ELOX) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:ELOX • US29014R2022

3.82 USD
-0.23 (-5.68%)
At close: Oct 13, 2023
2.8 USD
-1.02 (-26.7%)
After Hours: 10/13/2023, 8:00:02 PM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to ELOX. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 61.2. This target is 1502.09% above the current price.
  • ELOX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ELOX.
  • In the previous month the buy percentage consensus was at a similar level.
  • ELOX was analyzed by 7 analysts. More opinions would make the average more meaningful.
ELOX Historical Analyst RatingsELOX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -64 -58 -52 -46 -40 -34 -28 -22 -16 -10 -4 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 3.8260.6061.2061.2063.00 - 1,486.39% 1,502.09% 1,502.09% 1,549.21%
ELOX Current Analyst RatingELOX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-07-11 Oppenheimer Maintains Outperform -> Outperform
2023-04-06 Oppenheimer Reiterate Outperform
2022-05-23 Piper Sandler Maintains Overweight
2022-05-09 HC Wainwright & Co. Maintains Neutral
2021-12-17 Oppenheimer Initiate Outperform
2021-11-18 HC Wainwright & Co. Maintains Neutral
2021-11-11 HC Wainwright & Co. Maintains Neutral
2021-06-30 Mizuho Initiate Buy
2021-05-27 B. Riley Securities Initiate Buy

ELOXX PHARMACEUTICALS INC / ELOX FAQ

What is the average price target for ELOXX PHARMACEUTICALS INC (ELOX) stock?

7 analysts have analysed ELOX and the average price target is 61.2 USD. This implies a price increase of 1502.09% is expected in the next year compared to the current price of 3.82.


How do analysts rate ELOXX PHARMACEUTICALS INC (ELOX)?

The consensus rating for ELOXX PHARMACEUTICALS INC (ELOX) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed ELOXX PHARMACEUTICALS INC (ELOX)?

The number of analysts covering ELOXX PHARMACEUTICALS INC (ELOX) is 7.